Beddow Capital Management Inc. Sells 6,625 Shares of CVS Health Co. (NYSE:CVS)

Beddow Capital Management Inc. reduced its stake in CVS Health Co. (NYSE:CVS) by 12.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 47,510 shares of the pharmacy operator’s stock after selling 6,625 shares during the quarter. CVS Health comprises 1.2% of Beddow Capital Management Inc.’s holdings, making the stock its 28th largest holding. Beddow Capital Management Inc.’s holdings in CVS Health were worth $2,987,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also bought and sold shares of CVS. MidAtlantic Capital Management Inc. bought a new position in shares of CVS Health during the 3rd quarter worth about $25,000. Livelsberger Financial Advisory bought a new position in CVS Health in the third quarter worth approximately $31,000. Reston Wealth Management LLC acquired a new stake in CVS Health in the third quarter valued at approximately $32,000. First Community Trust NA raised its position in shares of CVS Health by 116.2% during the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after purchasing an additional 302 shares during the period. Finally, Kathleen S. Wright Associates Inc. acquired a new stake in CVS Health in the 3rd quarter valued at $33,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Performance

Shares of NYSE CVS opened at $56.08 on Tuesday. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 52-week low of $52.71 and a 52-week high of $83.25. The company has a market cap of $70.57 billion, a PE ratio of 14.23, a PEG ratio of 0.92 and a beta of 0.55. The firm’s 50-day moving average price is $59.19 and its 200-day moving average price is $58.60.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. During the same quarter last year, the business posted $2.21 earnings per share. The business’s quarterly revenue was up 6.3% compared to the same quarter last year. As a group, analysts anticipate that CVS Health Co. will post 5.48 EPS for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.74%. The ex-dividend date was Monday, October 21st. CVS Health’s dividend payout ratio is currently 67.51%.

Analysts Set New Price Targets

CVS has been the subject of a number of recent research reports. Barclays cut their price target on CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a report on Thursday, November 7th. Wells Fargo & Company raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $60.00 to $66.00 in a report on Monday. Evercore ISI raised their price target on shares of CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a report on Tuesday, October 8th. Royal Bank of Canada decreased their price target on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a report on Friday. Finally, Mizuho decreased their target price on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research note on Thursday, October 24th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and a consensus price target of $72.78.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.